Sancuso Patch
Product Images NDC 66220-637

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sancuso (NDC 66220-637). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cumberland Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (San0f 0000 01)

FDA Label Image

Figure (San0f 0000 02)

FDA Label Image

Figure (San0f 0000 03)

FDA Label Image

Figure (San0f 0000 04)

FDA Label Image

Figure (San0f 0000 05)

FDA Label Image

Figure (San0f 0000 06)

FDA Label Image

Figure (San0f 0000 07)

FDA Label Image

Principal Display Panel – 168 H Pouch Label (San0f 0000 08)

Principal Display Panel – 168 H Pouch Label (San0f 0000 08)
This is a description of the prescription medication Sancuso® which is a transdermal system containing 34.3 mg of granisetron. It is to be used transdermally and should not be cut. The system should be stored at 20° to 25°C and kept out of reach of children. The package includes 1 transdermal system and is for prescription use only. Manufactured for Cumberland Pharmaceuticals Inc. in Nashville, TN.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.